P h a r m a & H e a l t h c a r e C o n s u l t a n t s

United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020

2

© Pharmaion

I n d u s t r y B r i e f

United States Breast Cancer Diagnostic Devices Market to Cross $ 2 billion by 2020

Increasing awareness about the benefits of early diagnosis and growing technological advancements to driveUnited States breast cancer diagnostics devices market through 2020

According to Pharmaion report, “United States Breast Cancer Diagnostics Devices Market Opportunities,2010 - 2020”, breast cancer diagnostic devices market in the United States is projected to cross US$ 2 billion by2020. Growing prevalence of breast cancer, ageing demographics and rising awareness about breast cancerand early diagnosis are projected to propel growth in the United States breast cancer diagnostic devicesthrough 2020. Moreover, favorable reimbursement scenario in the country is encouraging citizens to visitdiagnostic laboratories and hospitals for breast cancer screening, consequently aiding growth of the breastcancer diagnostic devices market in the United States.

High prevalence of breast cancer and associated mortality is also motivating the government to take initiativesto improve breast cancer survival rate. Centers for Disease Control and Prevention (CDC) initiated NationalBreast and Cervical Cancer Early Detection Program (NBCCEDP) to provide timely breast and cervical cancerscreening, and breast cancer services to low income, uninsured and undeserved women in the United States.Moreover, various breast cancer associated non-profit organizations in the United States organize “BreastCancer Month” each year in November to increase awareness about the disease and promote the need forearly diagnosis.

In terms of test type, the United States breast cancer diagnostic devices market has been segmented intothree categories - screening and diagnostic imaging devices, lab diagnostic devices, and others. Screening anddiagnostic imaging devices dominated the United States breast cancer diagnostic devices market in 2014 andthe segment is anticipated to continue its dominance through 2020. South region, followed by Midwest, arethe leading regional markets for breast cancer diagnostic devices in the United States. Few of the leadingcompanies operating in the United States breast cancer diagnostic devices market include Hologic Inc.,Siemens Healthcare Diagnostics, Inc., Devicor Medical Products and GE Healthcare, among others.

3

T a b l e o f C o n t e n t s

© Pharmaion

S. No. Contents

1. Breast Cancer Diagnostic Devices Overview

2. United States Breast Cancer Epidemiology

3. Research Methodology

4. Analyst View

5. Global Breast Cancer Diagnostic Devices Market Overview

6. United States Breast Cancer Diagnostic Devices Market Overview

7. United States Breast Cancer Diagnostic Devices Market Outlook

7.1. Market Size and Forecast

7.1.1. By Value

7.2. Market Share and Forecast

7.2.1. By Test Type

7.2.2. By End-user

7.2.3. By Region

7.2.4. By Company

8. United States Screening and Diagnostic Imaging Devices Market Outlook

8.1. Market Size and Forecast

8.1.1. By Value

8.2. Market Share and Forecast

8.2.1. By Test Type

8.3. United States Mammography Market Outlook

8.3.1. Market Size and Forecast

8.3.1.1. By Value

8.3.2. Market Share and Forecast

4

T a b l e o f C o n t e n t s

© Pharmaion

S. No. Contents

8.3.2.1. By Type

9. United States Lab Diagnostic Devices Market Outlook

9.1. Market Size and Forecast

9.1.1. By Value

9.2. Market Share and Forecast

9.2.1. By Test Type

10. Market Dynamics

10.1. Drivers

10.2. Challenges

11. Market Trends & Developments

11.1. Contrast-enhanced Mammography

11.2. Novel Breast Cancer Diagnostics Biomarkers

11.3. Vacuum-Assisted Biopsy

11.4. CAD for Mammography

11.5. Scintimammography

12. United States Economic Profile

13. Regulatory Landscape

14. Reimbursement Scenario for Breast Cancer Diagnostic Procedures

15. Competitive Landscape

15.1. Competitive Benchmarking

15.2. Company Profiles

15.2.1. Hologic Inc.

15.2.2. Siemens Healthcare Diagnostics, Inc

5

T a b l e o f C o n t e n t s

© Pharmaion

S. No. Contents

15.2.3. Devicor Medical Products, Inc. (Mammotome)

15.2.4. GE Healthcare

15.2.5. Philips Healthcare

15.2.6. Carestream Health

15.2.7. Fujifilm Medical Systems, U.S.A., Inc.

15.2.8. IMS S.r.l.

15.2.9. Planmed OY

15.2.10. CareFusion Corporation

16. Strategic Recommendations

17. About US & Disclaimer

6

R e s e a r c h M e t h o d o l o g y

Primary Research

•Identifying Key Opinion Leaders

•Questionnaire Design

•In-depth Interviews

•Coverage across Value Chain market

Market Estimation & Forecasting

Bottom-Up or Top-down approach for Market size estimation

Historical trend examination

Impact analysis of drivers and challenges to market growth

Statistical evaluation to develop the actual forecast

Data Validation, Analysis and Interpretation

Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings

Preliminary Data Mining

Qualitative and Quantitative research

2015E 2016F 2017F 2018F 2019F 2020F

CAGR (2015E-2020F): XX%

US Breast Cancer Diagnostic Devices Market Opportunities, 2010-2020

Secondary Research

•Government websites

•Company annual reports

•White papers

•Investor presentation

•Financial reports

© Pharmaion

7

Baseline Methodology:

For the study of the United States breast cancer diagnostic devices market, Pharmaion has gathered

information through an exhaustive search of credible databases prudently evaluated all the collected

information and presented it in the most accurate and detailed manner.

Primary Sources

Key Stakeholders:

Product/Brand Managers

Business Development

Managers

Regional Mangers

Regulatory Affairs Personnel

Marketing & Sales Managers

Head of Patient Support

Programme

Substantial data points for analysis, interpretation and market size estimation

Data Triangulation

(Data validation

through cross verification

from primary & secondary

sources)

Qualitative and quantitative data from company

website, financial reports, research articles, designed

questionnaires etc.

In-depth interviews of key stakeholders of

major companies

Secondary Sources

Analysis of Data from credible sources: Centers for Disease Control

and Prevention (CDC) American Cancer Institute American College of

Radiology

© Pharmaion

R e s e a r c h M e t h o d o l o g y

8

Calculation of United States Breast Cancer

Screening and Diagnostic Imaging Devices, Lab

Diagnostic Devices and Others Market Size

Separately

United States Breast Cancer Diagnostic Devices Market - Market Size Estimation

United States breast cancer diagnostic devices market has been segmented into three categories,namely, Screening and Diagnostic Imaging Devices, Lab Diagnostic Devices and Others.

Screening and Diagnostic Imaging Devices segment has been further categorized into three sub-segments, i.e., Mammography, Breast Ultrasound and Breast MRI.

Lab Diagnostic Devices segment has been further classified into two sub-segments, namely, BreastBiopsy Devices and Lab Tests.

Calculation of United States Breast Cancer

Screening and Diagnostic Imaging Devices, Lab

Diagnostic Devices and Others Market Size

Separately

To

p-d

ow

n A

pp

ro

achB

otto

m-u

p A

pp

ro

ach

Calculation of Sub-

segment market size

Total Market Size =

Screening and Diagnostic Imaging

Devices + Lab Diagnostic Devices +

Others

Market Size (By Region and

Company) =

Respective Market Share (From Primary And Secondary Research)

XTotal Segment

Market Size

© Pharmaion

R e s e a r c h M e t h o d o l o g y

9

S a m p l e D a t a - S n a p s h o t

10 20 30 40 50 60 70 80 90 100 110

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

United States Breast Cancer Diagnostic Devices

Market Size, By Value, 2010-2020F (USD Billion)

© Pharmaion

United States Breast Cancer Diagnostic Devices

Market Share, By Test Type, By Value, 2010-2020F

5.0% 5.1% 5.2% 5.3% 5.4% 5.5% 5.6% 5.7% 5.8% 5.9% 6.0%

47% 47% 47% 47% 47% 47% 47% 47% 46% 46% 46%

45% 46% 47% 48% 49% 50% 51% 52% 53% 54% 55%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Screening and Diagnostic Imaging Devices

Lab Diagnostic Devices

Others

1020

3040

50

2010 2011 2012 2013 2014

North-East Region

10 20 30 40 50

2010 2011 2012 2013 2014

West Region

10 20 30 40 50

2010 2011 2012 2013 2014

Midwest Region

10 20 30 40 50

2010 2011 2012 2013 2014

South Region

United States Breast Cancer Diagnostic Devices Market

Size, By Region, By Value, 2010-2014 (USD Million) Segmental Revenue Break Up, FY 2015

Diagnostics, 25%

Breast Health, 25%

GYN surgical, 25%

Skeletal …

United States, …

Europe, …Asia-

Pacific, 25%

Other international markets, 25%

Hologic, Inc. (NASDAQ: HOLX)

By Business Segments

By Geography

Debt and Cash Availability (USD Million)

1020

5 10

FY 2015 FY 2014

Debt Cash and Cash Equivalent

United States Lab Diagnostic Devices Market Share, By Test Type, By Value, 2010-2020F

24% 25% 26% 27% 28% 29% 30% 31% 32% 33% 34%

76% 75% 74% 73% 72% 71% 70% 69% 68% 67% 66%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Breast Biopsy Lab Tests

Institutional, 50%

Non-institutional,

50%

Ownership Structure, 2014

R e p o r t O r d e r i n g

To View Sample OR Purchase Report

Report Price

Report Name: United States Breast Cancer Diagnostic Devices

Market Opportunities, 2010 - 2020

License Type Price

Single User License $2500

Single User License Print $3000

Enterprise License $5000

10

11

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

sales@pharmaion.com

+1 646 862 0089

www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides itscustomers with high value market research and advisory services that helps them identify new market opportunities, growthengines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow markettrends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and anincreased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditionalmarket research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable andinteractive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market researchand consulting requirements.

Related Reports

India Stem Cell Market Forecast & Opportunities, 2010-2020

India Infertility Treatment Market Forecast & Opportunities, 2010-2020

Global Tissue Engineered Medical Device Market Forecast & Opportunities, 2010-2020

Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation ismade that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has beenobtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee theaccuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from theuse of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. Theinformation herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicativeof relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require priorapproval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

sales@pharmaion.com

+91 - 120 - 452 3900

www.pharmaion.com © Pharmaion